Pacific Edge cuts losses by $4.7m on US growth

Pacific Edge cuts losses by $4.7m on US growth
Total lab throughput for tests dipped 6% compared to the prior year.
Brent Melville
Cancer diagnostics firm Pacific Edge has slowed its cash burn on the strength of key wins in its core US market, trimming net losses after tax by a quarter, or $4.7 million, to $14.2m for the year to March.That came off a more than doubling in revenue to $10.4m from a comparable $5.2m in 2020, with operating revenue from test sales at $7.7m, driven by inroads into the commercialisation of its Cxbladder product into international markets.Chief executive David Darling said the result had been achieved despite headwinds created by covid particular...

More Markets

Entain makes play at one of SkyCity’s revenue streams
Markets

Entain makes play at one of SkyCity’s revenue streams

Entain and TAB NZ want exclusive rights to 'virtual sports'.

NZ sharemarket starts week down 0.2%
Markets Market Close

NZ sharemarket starts week down 0.2%

The S&P/NZX 50 Index closed at 12,876.35, down 25.84 points or 0.2%.

Graham Skellern 10 Feb 2025
Red carpet for foreign investors at March summit
Policy

Red carpet for foreign investors at March summit

The summit will showcase NZ infrastructure investment opportunities.

Pattrick Smellie 10 Feb 2025
Genesis in talks with Foresta for major Huntly biofuels deal
Markets

Genesis in talks with Foresta for major Huntly biofuels deal

Foresta says it could produce more than 300,000 tonnes of energy-dense biofuel a year.

Greg Hurrell 10 Feb 2025